PLANT ADVANCED TECHNOLOGIES (ALPAT.PA) Stock Fundamental Analysis

EPA:ALPAT • FR0010785790

8.4 EUR
0 (0%)
Last: Feb 11, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

3

Overall ALPAT gets a fundamental rating of 3 out of 10. We evaluated ALPAT against 81 industry peers in the Biotechnology industry. ALPAT may be in some trouble as it scores bad on both profitability and health. ALPAT has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

  • ALPAT had positive earnings in the past year.
  • In multiple years ALPAT reported negative net income over the last 5 years.
  • The reported operating cash flow has been mixed in the past 5 years: ALPAT reported negative operating cash flow in multiple years.
ALPAT.PA Yearly Net Income VS EBIT VS OCF VS FCFALPAT.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1M -1M 2M -2M

1.2 Ratios

  • The Return On Assets of ALPAT (2.00%) is better than 76.54% of its industry peers.
  • Looking at the Return On Equity, with a value of 3.43%, ALPAT is in the better half of the industry, outperforming 79.01% of the companies in the same industry.
Industry RankSector Rank
ROA 2%
ROE 3.43%
ROIC N/A
ROA(3y)1.25%
ROA(5y)-1.47%
ROE(3y)2.03%
ROE(5y)-3.1%
ROIC(3y)N/A
ROIC(5y)N/A
ALPAT.PA Yearly ROA, ROE, ROICALPAT.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 -10 -15

1.3 Margins

  • With an excellent Profit Margin value of 34.16%, ALPAT belongs to the best of the industry, outperforming 90.12% of the companies in the same industry.
  • ALPAT's Gross Margin of 145.40% is amongst the best of the industry. ALPAT outperforms 100.00% of its industry peers.
  • ALPAT's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM N/A
PM (TTM) 34.16%
GM 145.4%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.17%
GM growth 5Y-4.76%
ALPAT.PA Yearly Profit, Operating, Gross MarginsALPAT.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 -200

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. Health

2.1 Basic Checks

  • ALPAT does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, ALPAT has more shares outstanding
  • The number of shares outstanding for ALPAT has been increased compared to 5 years ago.
  • Compared to 1 year ago, ALPAT has an improved debt to assets ratio.
ALPAT.PA Yearly Shares OutstandingALPAT.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 200K 400K 600K 800K 1M
ALPAT.PA Yearly Total Debt VS Total AssetsALPAT.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

2.2 Solvency

  • ALPAT has an Altman-Z score of 0.54. This is a bad value and indicates that ALPAT is not financially healthy and even has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of 0.54, ALPAT is in line with its industry, outperforming 58.02% of the companies in the same industry.
  • ALPAT has a Debt/Equity ratio of 0.40. This is a healthy value indicating a solid balance between debt and equity.
  • ALPAT has a Debt to Equity ratio (0.40) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF N/A
Altman-Z 0.54
ROIC/WACCN/A
WACC6.87%
ALPAT.PA Yearly LT Debt VS Equity VS FCFALPAT.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M 4M 6M 8M 10M

2.3 Liquidity

  • A Current Ratio of 0.88 indicates that ALPAT may have some problems paying its short term obligations.
  • ALPAT has a Current ratio of 0.88. This is in the lower half of the industry: ALPAT underperforms 70.37% of its industry peers.
  • ALPAT has a Quick Ratio of 0.88. This is a bad value and indicates that ALPAT is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 0.31, ALPAT is doing worse than 90.12% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.88
Quick Ratio 0.31
ALPAT.PA Yearly Current Assets VS Current LiabilitesALPAT.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. Growth

3.1 Past

  • ALPAT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -73.00%.
  • ALPAT shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -63.00%.
  • The Revenue has been growing by 10.44% on average over the past years. This is quite good.
EPS 1Y (TTM)-73%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-135.71%
Revenue 1Y (TTM)-63%
Revenue growth 3Y-5.79%
Revenue growth 5Y10.44%
Sales Q2Q%-86.85%

3.2 Future

  • Based on estimates for the next years, ALPAT will show a very strong growth in Earnings Per Share. The EPS will grow by 68.40% on average per year.
  • The Revenue is expected to grow by 31.88% on average over the next years. This is a very strong growth
EPS Next Y97.01%
EPS Next 2Y68.4%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year13.04%
Revenue Next 2Y31.88%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ALPAT.PA Yearly Revenue VS EstimatesALPAT.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1M 2M 3M 4M
ALPAT.PA Yearly EPS VS EstimatesALPAT.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 0.5 -0.5 -1 -1.5 -2

More info and screens

Find the best growth stocksShow best growing peers

5

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 31.11, the valuation of ALPAT can be described as expensive.
  • Based on the Price/Earnings ratio, ALPAT is valued cheaply inside the industry as 81.48% of the companies are valued more expensively.
  • The average S&P500 Price/Earnings ratio is at 27.67. ALPAT is around the same levels.
  • With a Price/Forward Earnings ratio of 14.56, ALPAT is valued correctly.
  • ALPAT's Price/Forward Earnings ratio is rather cheap when compared to the industry. ALPAT is cheaper than 96.30% of the companies in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 27.69. ALPAT is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 31.11
Fwd PE 14.56
ALPAT.PA Price Earnings VS Forward Price EarningsALPAT.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ALPAT indicates a somewhat cheap valuation: ALPAT is cheaper than 76.54% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 54.62
ALPAT.PA Per share dataALPAT.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

  • ALPAT's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as ALPAT's earnings are expected to grow with 68.40% in the coming years.
PEG (NY)0.32
PEG (5Y)N/A
EPS Next 2Y68.4%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • ALPAT does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

PLANT ADVANCED TECHNOLOGIES

EPA:ALPAT (2/11/2026, 7:00:00 PM)

8.4

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)10-29
Earnings (Next)03-01
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners33.62%
Ins Owner ChangeN/A
Market Cap9.41M
Revenue(TTM)936.80K
Net Income(TTM)320.00K
Analysts84.44
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 31.11
Fwd PE 14.56
P/S 10.04
P/FCF N/A
P/OCF N/A
P/B 0.96
P/tB 1.53
EV/EBITDA 54.62
EPS(TTM)0.27
EY3.21%
EPS(NY)0.58
Fwd EY6.87%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0.84
BVpS8.71
TBVpS5.47
PEG (NY)0.32
PEG (5Y)N/A
Graham Number7.27
Profitability
Industry RankSector Rank
ROA 2%
ROE 3.43%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 34.16%
GM 145.4%
FCFM N/A
ROA(3y)1.25%
ROA(5y)-1.47%
ROE(3y)2.03%
ROE(5y)-3.1%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.17%
GM growth 5Y-4.76%
F-ScoreN/A
Asset Turnover0.06
Health
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF N/A
Debt/EBITDA 15.63
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.88
Quick Ratio 0.31
Altman-Z 0.54
F-ScoreN/A
WACC6.87%
ROIC/WACCN/A
Cap/Depr(3y)108.69%
Cap/Depr(5y)137.67%
Cap/Sales(3y)44.33%
Cap/Sales(5y)66.12%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-73%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-135.71%
EPS Next Y97.01%
EPS Next 2Y68.4%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-63%
Revenue growth 3Y-5.79%
Revenue growth 5Y10.44%
Sales Q2Q%-86.85%
Revenue Next Year13.04%
Revenue Next 2Y31.88%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-188.89%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year100%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y115.46%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y35.14%
OCF growth 3YN/A
OCF growth 5YN/A

PLANT ADVANCED TECHNOLOGIES / ALPAT.PA FAQ

Can you provide the ChartMill fundamental rating for PLANT ADVANCED TECHNOLOGIES?

ChartMill assigns a fundamental rating of 3 / 10 to ALPAT.PA.


What is the valuation status for ALPAT stock?

ChartMill assigns a valuation rating of 5 / 10 to PLANT ADVANCED TECHNOLOGIES (ALPAT.PA). This can be considered as Fairly Valued.


Can you provide the profitability details for PLANT ADVANCED TECHNOLOGIES?

PLANT ADVANCED TECHNOLOGIES (ALPAT.PA) has a profitability rating of 3 / 10.


What is the financial health of PLANT ADVANCED TECHNOLOGIES (ALPAT.PA) stock?

The financial health rating of PLANT ADVANCED TECHNOLOGIES (ALPAT.PA) is 1 / 10.